A blinded comparison of two methods of viral susceptibility testing: Plaque reduction assay versus microplate in situ ELISA

Journal of Virological Methods

Volumn 56, Issue 1, 1996, Pages 85-90

  Leahy, Bradley J ^a   Christiansen, Keryn J ^a   Collins, Peter ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; LABORATORY TEST; PRIORITY JOURNAL;

HERPES; SIMPLEXVIRUS;

EID: 0029942793     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(95)01957-X     Document Type: Article

References (13)

1. Berkowitz, F.E. and Levin, M.J. (1985) Use of an enzymelinked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob. Agents Chemother. 28, 207-210.
2. Collins, P. (1988) Viral sensitivity following the introduction of acyclovir. Am. J. Med. 85 (Suppl. 2A), 129-134.
3. Collins, P. and Darby, G. (1991) Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev. Med. Virol. 1, 19-28.
4. Dekker, C., Ellis, M.N., McLaren, C., Hunter, G., Rogers, J. and Barry, D.W. (1983) Virus resistance in clinical practice. J. Antimicrob. Chemother. 12, 137-152.
5. Finter, N.B. (1969) Dye-uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. Gen. Virol. 5, 419-427.
6. Kang, Jung-Oak, and Pai, Chik H. (1989) In situ enzyme immunoassay for antiviral susceptibility testing of Respiratory Syncytial Virus. Am. J. Clin. Pathol. 91, 323-326.
7. Leahy, B.J., Christiansen, K.J. and Shellam, G. (1994) Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir. J. Virol. Methods 48, 93-108.
8. McLaren, C., Ellis, M.N. and Hunter, G.A. (1983) A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 3, 223-234.
9. Parris, D.S. and Harrington, J.E. (1982) Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob. Agents Chemother. 22, 71-77.
10. Safrin, S., Elbeik, T., Phan, L., Robinson, D., Rush, J., Elbaggari, A. and Mills, J. (1994a) Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38, 1246-1250.
11. Safrin, S., Kemmerly, S., Plotkin, B., Smith, T., Weissbach, N., De Veranez, D., Phan, L. and Cohn, D. (1994b) Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J. Infect. Dis. 169, 193-196.
12. Smith, D.W. and Goodwin, C.S. (1988) The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir. J. Antimicrob. Chemother. 21.
13. van Tiel, F.H., Boere, W.A.M., Harmsen, T., Kraaaijeveld, C.A. and Snippe, H. (1985) Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidaselabeled monoclonal antibodies. Antimicrob. Agents Chemother. 27, 802-805.